Advertisement

Topics

Abraxis Pharmaceutical Products, Inc Company Profile

00:19 EST 17th December 2018 | BioPortfolio

Abraxis Pharmaceutical Products, Inc. is a specialty pharmaceutical company that fulfills an important need in the medical community as a provider of a broad portfolio of injectable pharmaceutical products, including difficult to manufacture, urgently needed medical products. Generic Injectable Business
APP's portfolio of more than 150 products ranks the company among the market share leaders in each of its areas of focus - oncology, anti-infective and critical care injectable pharmaceuticals. The company has a deep pipeline of approximately 50 products in various stages of development, which includes a number of product applications pending at the FDA. APP has expanded its product portfolio with the receipt of an industry leading 39 product approvals between 2001 and 2004. As of July 2005, the company continued this momentum with four new generic product approvals from the FDA.

Location

1501 East Woodfield Road, Suite 300 East
Schaumburg
Illinois
60173-5837
United States of America

Contact

Phone: (847) 413-2075
Fax: (800) 743-7082
Email: contactus@appdrugs.com


News Articles [450 Associated News Articles listed on BioPortfolio]

AiPing Pharmaceutical Strikes Ibuprofen Deal with Xinhua Pharmaceutical

AiPing Pharmaceutical, Inc. announced today that it has completed the sale of three ibuprofen Abbreviated New Drug Applications (ANDAs) in the U.S. to Shandong Xinhua Pharmaceutic...

The road to market: breaking down the stages of clinical trials for pharmaceutical products

According to the World Health Organisation (WHO) a clinical trial is defined as ‘any research study that prospectively assigns human...Read More... The post The road to market: breaking down the sta...

A Comprehensive Map of FDA-Approved Pharmaceutical Products

This article was originally published by Hao Zhong, Ging Chan, Yuanjia Hu, Hao Hu and Defang Ouyang in Pharmaceutics 2018, 10(4), 263 under a Creative Commons Attribution (CC BY) license (http://cr...

MGC Pharmaceuticals (MXC) - Cannabis-based medicines and cosmetics

Edison Investment Research - Pharmaceutical & healthcare - MGC Pharmaceuticals: MGC Pharmaceuticals is developing cannabis-based pharmaceutical products, initially in Australia and Europe. It has cann...

Pharmaceutical glass packaging market to grow at 6% CAGR

North America dominates the global market for pharmaceutical glass packaging, due to the region’s technical innovation and strong demand for pharmaceutical products... The post Pharmaceutical glass ...

D-Day Nearing For Antares Pharma

Shares of Antares Pharma Inc. (ATRS) have lost nearly 7% of their value so far this month, as the company's regulatory catalyst draws closer. Antares Pharma is a revenue-generating, specialty pharmace...

WHO Consults On Revised Scheme To Certify Quality Of Pharmaceutical Products

The WHO has proposed a revised certification scheme on the quality of pharmaceutical products to address recent changes in the...    

JW Pharmaceutical invests in British anti-cancer drugs developer

South Korea-based pharmaceutical products company JW Pharmaceutical has invested $2.6m in British anti-cancer drugs developer Argonaut Therapeutics. This investment gives...Read More... The post JW Ph...

Drugs and Medications [418 Associated Drugs and Medications listed on BioPortfolio]

Abraxane [Abraxis BioScience, LLC]

These highlights do not include all the information needed to use ABRAXANE safely and effectively. See full prescribing information for ABRAXANE ABRAXANE® for Injectable Suspension (paclitaxel protei...

Emetrol cherry [WellSpring Pharmaceutical Corporation]

Emetrol

Cetirizine hydrochloride [Pharmaceutical Associates, Inc.]

Cetirizine Hydrochloride Syrup

Giltuss total release [Gil Pharmaceutical Corp]

Drug Facts

Gilphex tr [Gil Pharmaceutical Corp]

Drug Facts

PubMed Articles [1359 Associated PubMed Articles listed on BioPortfolio]

The relationship between pharmacy benefit managers (PBMs) and the cost of therapies in the US pharmaceutical market: A policy primer for clinicians.

Pharmaceutical benefit managers (PBMs) are playing an increasingly important role in establishing access to pharmaceutical products for patients. PBMs set retail prices for pharmaceutical products, ne...

Impact of continuous flow chemistry in the synthesis of natural products and active pharmaceutical ingredients.

We present a comprehensive review of the advent and impact of continuous flow chemistry with regard to the synthesis of natural products and drugs, important pharmaceutical products and definitely res...

Assessing Recall and Recognition for Important Safety Information in Digital Promotion for Pharmaceutical Products: Implications for Website Design.

To date, there has been little research with digital direct-to-consumer (DTC) communication regarding pharmaceutical products (eg, product websites), so this study was designed to measure perception a...

Characterization of solution stress degradation products of aliskiren and prediction of their physicochemical and ADMET properties.

Forced degradation studies on aliskiren were carried out according to ICH and WHO guidelines. Six degradation products were formed in total in the solution state. Their separation among themselves and...

Over-the-counter Weight-Loss Herbal Supplements in Egypt: Label Claim, Microbiological, Pharmaceutical Quality and Safety Assessments.

Nutraceuticals are advertised and sold with the label claim of being natural and safe herbal products. Due to the absence of clear regulations and guidelines for safety assessments of these products, ...

Clinical Trials [1365 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Risperidone 1 mg Tablets of Torrent Pharmaceuticals Limited, India and Risperdal® (Risperidone) 1 mg Tablets of Janssen Pharmaceutical Products, LP, USA, in Healthy Human Adult Subjects, Under Fed Conditions

Objective: - To assess the bioequivalence of Risperidone 1.0 mg tablets of Torrent Pharmaceuticals Limited., India and Risperdal® (Risperidone) 1.0 mg tablets of Janssen Pharmace...

Clinical Impact of Pharmaceutical Consultations in Patients Treated for Chronic Obstructive Pulmonary Disease at Home

The implementation of pharmaceutical consultations in the city or at the hospital could modify the occurrence of exacerbations related to chronic obstructive pulmonary disease after return...

Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...

A Study Comparing the Bioequivalence of Triamcinolone Acetonide Aqueous Nasal Spray (Apotex, Inc.) to That of Nasacort® AQ Nasal Spray (Sanofi-Aventis Pharmaceutical Products, Inc.) In the Treatment of Seasonal Allergic Rhinitis

A randomized, double-blind, placebo-controlled parallel-group study, comparing the bioequivalence of triamcinolone acetonide aqueous nasal spray (Apotex, Inc.) to that of Nasacort® AQ nas...

Companies [2654 Associated Companies listed on BioPortfolio]

Abraxis Pharmaceutical Products, Inc

Abraxis Pharmaceutical Products, Inc. is a specialty pharmaceutical company that fulfills an important need in the medical community as a provider of a broad portfolio of injectable pharmaceutical pro...

Abraxis Bioscience

Abraxis BioScience is an integrated, global biopharmaceutical company dedicated to meeting the needs of critically ill patients. The company develops, manufactures, and markets one of the broadest por...

Abraxis BioScience, Inc.

Abraxis BioScience is a fully integrated global biotechnology company dedicated to the discovery, development and delivery of next-generation therapeutics and core technologies th...

P V S P H A R M A

Our Pharmaceutical products solution is focused to help manage the success of client’s business. We thrive on our innovative methodology to provide solution at an unmatched time to delivery and pr...

Osmotica Pharmaceutical Corp.

Osmotica Pharmaceutical is a global specialty pharmaceutical company with a proven history of developing commercially successful pharmaceutical products. The company uses its prop...

More Information about "Abraxis Pharmaceutical Products, Inc" on BioPortfolio

We have published hundreds of Abraxis Pharmaceutical Products, Inc news stories on BioPortfolio along with dozens of Abraxis Pharmaceutical Products, Inc Clinical Trials and PubMed Articles about Abraxis Pharmaceutical Products, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Abraxis Pharmaceutical Products, Inc Companies in our database. You can also find out about relevant Abraxis Pharmaceutical Products, Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record